Archives

June 26, 2019
Major Trends

What industry trend do you think will have the biggest impact on your workers’ comp program in the next year?...

READ MORE
June 25, 2019
Program Priorities

Rank the below items in order of priority for your organization’s workers’ comp program....

READ MORE
June 24, 2019
Program Successes

What workers’ comp program has your organization implemented that you’re finding the most success with?...

READ MORE
December 8, 2018
Heroโ€™s Welcome: Growing PTSD Coverage for First Responders

...body is unharmed. Should workers’ compensation coverage extend to these scenarios? A growing number of states think it should. In 2018 alone, 16 states considered legislation to address workers’ comp...

READ MORE
April 8, 2020
Sandy Shtab: Regulatory Acceleration in Response to COVID-19

Healthesystems’ AVP of Advocacy & Compliance, Sandy Shtab, was featured in WorkCompWire’s Leaders Speak Series, discussing regulatory acceleration in response to COVID-19. In the article, Sandy covers federal and state responses, the...

READ MORE
April 22, 2022
Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results

A new, non-opioid pain medication from Vertex Pharmaceuticals demonstrated positive results in Phase 2 proof of concept trials, showing promise for other potential indications in pain management. VX-548 was tested...

READ MORE
November 30, 2020
FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

...years of age and older, weighing at least 40 kilograms (88 pounds) and should only be administered in a hospital or healthcare setting capable of providing acute care comparable to...

READ MORE
January 7, 2018
No End in Sight for the Opioid Epidemic?

...in the workers’ compensation industry have become experts in managing this particular area of concern, these latest numbers remind us that opioid management continues to be more important than ever....

READ MORE
March 18, 2020
COVID-19 and Clinical Trials

Many clinical trials are underway for drugs to combat COVID-19, but the FDA gave special notice to two drugs. Gilead Sciences initiated two Phase 3 studies of the investigational antiviral...

READ MORE
March 21, 2024
New Autoimmune Biosimilar Approved and Alzheimerโ€™s Drug Goes Generic

...Alzheimer’s could interfere with medication adherence, particularly if patients also have a comorbidity. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....

READ MORE
1 43 44 45 46 47 49
lockenvelopephone-handsetmagnifiermenucross-circle